LMX1B mutations with nails and kneecaps: a new paradigm?

tation from older living donors. Transplantation 2013; 95: 106–113 20. Fuggle SV, Allen JE, Johnson RJ et al. Factors affecting graft and patient survival after live donor kidney transplantation in the UK. Transplantation 2010; 89: 694–701 21. Chang P, Gill J, Dong J et al. Living donor age and kidney allograft half-life: implications for living donor paired exchange programs. Clin J Am Soc Nephrol 2012; 7: 835–841 22. Noppakun K, Cosio FG, Dean PG, Taler SJ, Wauters R, Grande JP. Living donor age and kidney transplant outcomes. Am J Transplant 2011; 11: 1279–1286 23. Young A, Kim SJ, Speechley MR et al. Accepting kidneys from older living donors: impact on transplant recipient outcomes. Am J Transplant 2011; 11: 743–750 24. Tso PL, Dar WA, Henry ML. With respect to elderly patients: finding kidneys in the context of new allocation concepts. Am J Transplant 2012; 12: 1091–1098 25. Rook M, Hofker HS, van Son WJ, Homan van der Heide JJ, Ploeg RJ, Navis GJ. Predictive capacity of pre-donation GFR and renal reserve capacity for donor renal function after living kidney donation. Am J Transplant 2006; 6: 1653–1659 26. Young A, Storsley L, Garg AX et al. Health outcomes for living kidney donors with isolated medical abnormalities: a systematic review. Am J Transplant 2008; 8: 1878–1890 27. Ommen ES, Winston JA, Murphy B. Medical risks in living kidney donors: absence of proof is not proof of absence. Clin J Am Soc Nephrol 2006; 1: 885–895